Dimera Incorporated is a specialized west coast biotechnology company dedicated to discovering novel medical concepts to address important medical needs (i.e., the leading cause of death and dysfunction, which is heart and blood vessel disease). Dimera focuses on developing safe and effective medicines to reduce the risk of heart disease and blood vessel dysfunction by discovering and treating causes--rather than symptoms. This more arduous path has important virtues, importantly responding on target to unmet needs while simultaneously avoiding or minimizing side-effects. The result of this rational approach is a new prescription medicine, DP9, which has progressed through 2 of 3 phases of FDA randomized controlled clinical trials, that promises to solve the unmet need revealed by the large Women's Health Initiative clinical trial of Prempro (which contained medroxyprogesterone acetate, or MPA). Our Nature Clinical Practice Cardiovascular Medicine review contrasts the beneficial heart and blood vessel actions of progesterone on the heart with the ineffectiveness and uncertainties of commonly prescribed MPA.
View Top Employees from Dimera IncorporatedWebsite | http://www.dimera.net |
Revenue | $6 million |
Employees | View employees |
Address | PO Box 56600, Portland, Oregon 97238, US |
Phone | (503) 295-2757 |
Fax | (503) 295-2757 |
Industry | Manufacturing General, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Dimera Incorporated employee's phone or email?
The Dimera Incorporated annual revenue was $6 million in 2024.
Dimera Incorporated is based in Portland, Oregon.
The NAICS codes for Dimera Incorporated are [3254, 325, 32, 32541].
The SIC codes for Dimera Incorporated are [283, 28].